# Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye

> **NCT00724412** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 279 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **OTHER:** Systane
- **OTHER:** Optive

## Key facts

- **NCT ID:** NCT00724412
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724412, "Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00724412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*